One Bio Stock

One Bio ROE

The Return on Equity (ROE) of One Bio (ONBI) as of Jul 21, 2026 is 20.61 %.

ROE

20.61 %

Last updated:

In 2026, One Bio's return on equity (ROE) was 20.61 %, a % increase from the - ROE in the previous year.

Access this data via the Eulerpool API

One Bio Stock analysis

What does One Bio do? One Bio Corp is a US-based company specializing in biotechnological research, development, and production of biological and similar products. The company is headquartered in Miami, Florida and was founded in 1978. The history of One Bio Corp began with the development of enzymatic cleaning agents for the carpet industry in the late 1970s. Over the years, the company has become a key player in the field of biotechnology and the life sciences through acquisitions, mergers, and partnerships. Through its research and development efforts, One Bio Corp has been able to develop a wide range of products and services for various industries such as pharmaceuticals, cosmetics, food, animal feed, agriculture, and environmental technology. One Bio Corp offers a wide range of products for various applications. These include DNA test kits for pets and horses, dietary supplements for humans and animals, as well as pesticides and fungicides for agriculture. Additionally, One Bio Corp also provides diagnostic and testing services for infectious diseases and other health-related tests. One Bio Corp has several divisions focusing on different aspects of biotechnology and biological research. This includes the Life Sciences division, which focuses on the development of dietary supplements, diagnostic tests, and cosmetic products. The Agricultural Solutions division offers pesticides, fungicides, and other products for agriculture. The Veterinary Diagnostics division provides DNA test kits for pets and horses. Lastly, the Environmental Solutions division specializes in the development of products and services to improve environmental quality. One Bio Corp's business model is focused on long-term growth and success. The company concentrates on developing products and services that meet the needs of customers and end consumers. One Bio Corp pursues a strong marketing and distribution strategy to successfully market and promote its products and services. Additionally, the company collaborates closely with partners and research institutions to develop innovative technologies and products. Overall, One Bio Corp is an innovative biotechnological company that focuses on developing products and services tailored to the needs of customers and end consumers. The company follows a clear business strategy and relies on innovative research and development to achieve long-term growth and success. One Bio is one of the most popular companies on Eulerpool.

ROE Details

Decoding One Bio's Return on Equity (ROE)

One Bio's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing One Bio's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

One Bio's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in One Bio’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about One Bio stock

Return on Equity (ROE) of One Bio is 20.61 % in 2026.

Access this data via the Eulerpool API

Profitability — One Bio

All Key Metrics — One Bio